Neoleukin Therapeutics

Neoleukin Therapeutics: Develops next-generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface. NL-201 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory cancer and the company is expecting interim data in 2022. Cash $164.2M as of June 30, 2021; sufficiently capitalized to fund operations into 2023
Sector/Industry:
Healthcare/Drug Manufacturers
Characteristics:
Based in...
US - Pacific
Clinical Stage
Pre-Clinical Stage
Disease Space
Allergy, Autoimmune, Immuno-Oncology, Infectious Disease, Oncology
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Profiles:
Address:
1616 Eastlake Avenue E
Suit 360
Seattle, WA 98109
United States

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Jonathan G. Drachman, Pres/CEO

Upcoming Company Event Participation

Top 10 Holders of Neoleukin Therapeutics, Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Baker Bros. Advisors LP 9.01 3,821,740 19.53 13F 9/30/21
Redmile Group LLC 8.27 3,507,235 17.92 13F 9/30/21
Pictet Asset Management SA 6.28 2,664,491 13.62 13F 9/30/21
The Vanguard Group, Inc. 3.78 1,601,635 8.18 Funds 10/31/21
BlackRock Fund Advisors 3.76 1,596,921 8.16 13F 9/30/21
Vanguard Group, Inc. (Subfiler) 3.64 1,545,933 7.90 13F 9/30/21
Boxer Capital LLC 3.54 1,501,058 7.67 13F 9/30/21
Opaleye Management, Inc. 2.47 1,047,300 5.35 13F 9/30/21
Point72 Asset Management LP (Old) 2.36 1,000,000 5.11 13F 9/30/21
Ecor1 Capital LLC 2.03 860,619 4.40 13F 9/30/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.